MA05.01 Patients’ Experiences During COVID-19: Insights from the Second Global Lung Cancer Coalition Patient Experience Survey

The Global Lung Cancer Coalition (GLCC) is a partnership of 41 patient organisations across 30 nations, dedicated to improving outcomes for lung cancer patients. In 2020, the GLCC conducted its first global patient experience survey, using member networks to canvas patients' opinions on their care. In 2021, the GLCC wanted to explore how COVID-19 had affected patients' experiences of lung cancer care, so determined to undertake a second survey.